佐力药业(300181.SZ)发布前三季度业绩，归母净利润5.1亿元，增长21.00%

Core Viewpoint - Zhaoli Pharmaceutical (300181.SZ) reported a revenue of 2.28 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 11.48% [1] - The net profit attributable to shareholders reached 510 million yuan, marking a year-on-year increase of 21.00% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 509 million yuan, with a year-on-year growth of 22.51% [1] - The basic earnings per share stood at 0.7271 yuan [1]